Teleflex Awarded Group Purchasing Contract with Vizient

8/23/17

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies for vascular access, has announced a new three year Product Category contract with Vizient Inc. for non-tunneled central venous catheters. Vizient is the largest member-driven health care performance improvement company in the country.

The new agreement for non-tunneled central venous catheters, which became effective August 1, 2017, provides Vizient’s members increased savings on contracts that offer Teleflex’s wide range of catheter kits, which are designed to protect patients against unnecessary catheter related complications.

“Teleflex is pleased to offer such an extensive line of products to Vizient members,” said Jake Newman, vice president and general manager, Vascular Access, Teleflex. “Agreements like these demonstrate our commitment to working with all parties in the healthcare system to offer technology at increased savings that helps clinicians improve outcomes while reducing healthcare costs.”

Vizient’s diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.